by SiliCYCLE
SiliaChrom XDB1 phases present a complete normal phases family HPLC columns (SiO2, Diol, CN, AMINO). These phases present the maximum bonding density. This allows least interaction between the analytes and the surface OH's.
SiliaChrom® XDB1 CN is a versatile stationary phase which can be used in normal phase or reverse phase conditions. This stationary phase is ideal for basic pharmaceuticals, steroids and other basic compounds.
| Vendor | SiliCYCLE | Max Pressure | 5500 |
| Brand | SiliaChrom XDB1 CN | Surface Area | 380-400 |
| Modifification | Silica/CN | Carbon Load, % | 5.0 |
| Mode | Normal-Phase/Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability from | 2.0 | |
| Internal Diameter | pH stability to | 9.0 | |
| Pore size | 100 |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Vertical Chromatography | VertiSep BDS CN | Normal-Phase/Reversed-Phase | Silica/CN | 4.6 mm | 150 mm | 5.0 μm | 140 Å | On request |
| Vertical Chromatography | VertiSep UPS CN | Normal-Phase/Reversed-Phase | Silica/CN | 7.8 mm | 100 mm | 3 μm | 100 Å | On request |
| KNAUER | Eurospher I | Normal-Phase/Reversed-Phase | Silica/CN | 8.0 mm | 120 mm | 5.0 μm | 100 Å | On request |
| ACE | ACE CN-300 | Normal-Phase/Reversed-Phase | Silica/CN | 4.6 mm | 150 mm | 3.0 μm | 300 Å | On request |
| Welch Materials | Ultisil XB-CN | Normal-Phase/Reversed-Phase | Silica/CN | 2.1 mm | 50 mm | 3.0 μm | 120 Å | On request |
| — | — | Normal-Phase/Reversed-Phase | Silica/CN | 2.0 mm | 50 mm | 10 μm | 120 Å | On request |
| ACE | ACE CN | Normal-Phase/Reversed-Phase | Silica/CN | 4.0 mm | 150 mm | 5.0 μm | 100 Å | On request |
| KNAUER | Eurospher I | Normal-Phase/Reversed-Phase | Silica/CN | 32.0 mm | 30 mm | 5.0 μm | 100 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
